Table 4.

PGMY-CHUV reproducibility analysis: genotype-specific analysis^a

Genotype	No. of samples for each resultb				% Agreement	κ	95% CI	Intc
	−/−	+/−	−/+	+/+
6	262	3	0	10	98.91	0.864	0.711–1.017	NP
11	272	0	0	3	100	1.000	1.000–1.000	PE
16	236	3	0	36	98.91	0.954	0.902–1.006	NP
18	266	0	0	9	100	1.000	1.000–1.000	PE
26	275	0	0	0	NAd	NA	NA	NA
31	257	3	0	15	98.91	0.903	0.795–1.012	NP
33	267	0	0	8	100	1.000	1.000–1.000	PE
34	274	1	0	0	99.64	0.000	−1.956–1.956	W
35	257	0	0	18	100	1.000	1.000–1.000	PE
39	268	0	0	7	100	1.000	1.000–1.000	PE
40	275	0	0	0	NA	NA	NA	NA
42	258	2	2	13	98.55	0.859	0.722–0.996	NP
44	266	0	1	8	99.64	0.939	0.821–1.058	NP
45	264	1	1	9	99.27	0.896	0.753–1.040	NP
51	259	1	0	15	99.64	0.966	0.899–1.033	NP
52	256	2	2	15	98.55	0.875	0.753–0.997	NP
53	242	1	1	31	99.27	0.965	0.916–1.013	NP
54	269	0	1	5	99.64	0.907	0.726–1.089	NP
55	263	2	1	9	98.91	0.851	0.684–1.019	NP
56	257	0	2	16	99.27	0.937	0.851–1.024	NP
57	275	0	0	0	NA	NA	NA	NA
58	245	3	1	26	98.55	0.920	0.843–0.998	NP
59	265	0	0	10	100	1.000	1.000–1.000	PE
66	259	1	1	14	99.27	0.929	0.832–1.027	NP
68	268	0	0	7	100	1.000	1.000–1.000	PE
69	275	0	0	0	NA	NA	NA	NA
70	263	1	0	11	99.64	0.955	0.866–1.043	NP
73	266	1	1	7	99.27	0.871	0.693–1.049	NP
82	270	0	2	3	99.27	0.747	0.397–1.097	S
83	268	2	0	5	99.27	0.830	0.595–1.065	NP
84	269	0	1	5	99.64	0.907	0.726–1.089	NP
Othere	242	3	0	30	98.91	0.946	0.886–1.007	NP
Total	8,408	30	17	345	99.47	0.933	0.914–0.952	NP

^aThe total number of samples was 275, giving 8,800 possible genotype-sample combinations.

^b−/−, Negative on original as well as on retesting; −/+, original negative and retesting positive; +/−, original positive and retesting negative; +/+, positive on original as well as on retesting.

^cInterpretation of the κ values. PE, perfect; NP, near perfect; S, strong; W, weak.

^dNA, not applicable.

^eOther HPV genotypes not on the probe array and considered a single group (61, 62, 71, 72, 74, 81, 89, 114, HLT7474S, and unknown).